Your browser doesn't support javascript.
loading
Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2.
Catucci, Irene; Casadei, Silvia; Ding, Yuan Chun; Volorio, Sara; Ficarazzi, Filomena; Falanga, Anna; Marchetti, Marina; Tondini, Carlo; Franchi, Michela; Adamson, Aaron; Mandell, Jessica; Walsh, Tom; Olopade, Olufunmilayo I; Manoukian, Siranoush; Radice, Paolo; Ricker, Charite; Weitzel, Jeffrey; King, Mary-Claire; Peterlongo, Paolo; Neuhausen, Susan L.
Afiliação
  • Catucci I; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
  • Casadei S; Departments of Medicine and Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
  • Ding YC; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
  • Volorio S; Cogentech, Cancer Genetic Test Laboratory, Milan, Italy.
  • Ficarazzi F; Cogentech, Cancer Genetic Test Laboratory, Milan, Italy.
  • Falanga A; Department of Immunohematology and Transfusion Medicine, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Marchetti M; Department of Immunohematology and Transfusion Medicine, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Tondini C; Unit of Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Franchi M; Unit of Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Adamson A; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
  • Mandell J; Departments of Medicine and Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
  • Walsh T; Departments of Medicine and Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
  • Olopade OI; Department of Medicine, Center for Clinical Cancer Genetics and Global Health, University of Chicago, Chicago, IL, USA.
  • Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ricker C; Department Medicine, Keck School of Medicine at University of Southern California, Los Angeles, CA, USA.
  • Weitzel J; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
  • King MC; Departments of Medicine and Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
  • Peterlongo P; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
  • Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. sneuhausen@coh.org.
Breast Cancer Res Treat ; 160(1): 121-129, 2016 11.
Article em En | MEDLINE | ID: mdl-27624329
ABSTRACT

PURPOSE:

Breast cancer-predisposing mutations PALB2 c.1027C>T (p.Gln343*) and PALB2 c.2167_2168delAT have each been observed multiple times in breast cancer families of Italian ancestry. More recently, the c2167_2168delAT mutation was identified in unrelated breast cancer cases of various ancestries. For each mutation, we investigated whether the origin was multiple mutational events (a "hot-spot") or a single event (a founder allele).

METHODS:

We genotyped and reconstructed haplotypes for 36 participants of Italian, Italian-American, Hispanic, and Nigerian ancestries, using seven short tandem repeat (STR) markers that covered 3 Megabases within and flanking PALB2 on chromosome 16.

RESULTS:

For PALB2 c.1027C>T, a shared haplotype with a minimum size of 150 kb was shared by all 19 carriers investigated, all of Italian ancestry. This result suggests that this allele arose as a single event in a shared ancestor. For PALB2 c.2167_2168delAT, all 12 carriers from American-Italian and Italian families shared a 1-Mb haplotype, the 3 Hispanic carriers shared a different haplotype of size 2 Mb, and the Nigerian carrier had different alleles at all 7 STR markers. These results suggest that PALB2 c.2167_2168delAT arose multiple times, but that within each population, PALB2 c.2167_2168delAT likely represents a single mutational event.

CONCLUSION:

We identified two PALB2 mutations that are founder alleles in Italian families, one of which is, independently, also a founder mutation in American-Hispanic breast cancers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Haplótipos / Neoplasias da Mama / Predisposição Genética para Doença / Alelos / Proteína do Grupo de Complementação N da Anemia de Fanconi / Mutação Limite: Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Haplótipos / Neoplasias da Mama / Predisposição Genética para Doença / Alelos / Proteína do Grupo de Complementação N da Anemia de Fanconi / Mutação Limite: Female / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article